Pathology Lab Boosts Lease to 35,000 SF

The locally based Veripath Laboratories will be occupying 35,000 sf of 2110 Research Row BioLabs in a co-terminus, long-term lease with its original 7,500-sf pact, says Lawrence G. Moser, president of Moser Realty Group in Dallas. The latest lease takes the BioLabs building to 80% occupancy. The specialty space is on the market for $10 per sf to $12 per sf, triple net.

Moser says the Veripath expansion required gutting of the basement, second and third floors along with half of the fourth and sixth floors. The firm was founded to provide pathology services to the Southwestern Medical Center, but now is expanding select procedures for outsourcing to hospitals in North Texas, Louisiana and Oklahoma. The BioLabs building has a tunnel leading to the South Rehabilitation Hospital and sits two miles north of Southwestern Medical's campus. Furstenberg Construction Co. of Dallas is doing the build-out.

Moser Realty bought the building from Carter Bloodcare and has been gradually transitioning the property into just biomed use. This year's activity has put Tissuegen, a medical device company, into 2,700 sf; Macrocyclics, a molecular imaging firm, into 3,500 sf; Biological Targets, which focuses on agriculture, into 6,500 sf; and Hemobiotech, a blood substitute company, into 200 sf while talks continue for expansion space.

With 2110 Research Row pushing 100%, Moser says he's actively looking for other conversion candidates, focusing on warehouse properties in the Stemmons-Trinity-Brookhollow submarkets. "We have some contracts working to purchase more buildings to convert to lab space," he tells GlobeSt.com.